GlaxoSmithKline
GSK
#209
Rank
NZ$169.15 B
Marketcap
NZ$83.80
Share price
-0.33%
Change (1 day)
47.58%
Change (1 year)

GlaxoSmithKline (GSK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$106.08 Billion

According to GlaxoSmithKline's latest financial reports the company's total liabilities are NZ$106.08 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlaxoSmithKline - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$103.19 B10.85%
2023-12-31NZ$93.09 B-2.39%
2022-12-31NZ$95.37 B-16.45%
2021-12-31NZ$114.14 B1.34%
2020-12-31NZ$112.63 B-5.68%
2019-12-31NZ$119.42 B16.02%
2018-12-31NZ$102.93 B2.27%
2017-12-31NZ$100.65 B4.41%
2016-12-31NZ$96.40 B-0.1%
2015-12-31NZ$96.50 B35.98%
2014-12-31NZ$70.96 B3.16%
2013-12-31NZ$68.79 B0.78%
2012-12-31NZ$68.26 B6.28%
2011-12-31NZ$64.23 B-1.18%
2010-12-31NZ$65.00 B-9.17%
2009-12-31NZ$71.56 B-8.82%
2008-12-31NZ$78.48 B43.31%
2007-12-31NZ$54.76 B23.87%
2006-12-31NZ$44.20 B-10.71%
2005-12-31NZ$49.50 B11.58%
2004-12-31NZ$44.37 B4.1%
2003-12-31NZ$42.62 B-6.87%
2002-12-31NZ$45.76 B-3.39%
2001-12-31NZ$47.37 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
NZ$118.54 B 11.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$200.16 B 88.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.39 B 26.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.25 B 2.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$114.29 B 7.74%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
NZ$56.43 B-46.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ$0.71 B-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA